Question 1

What is Pacira BioSciences, Inc. Common Stock's WACC?

Accepted Answer

Pacira BioSciences, Inc. Common Stock (PCRX) has a Weighted Average Cost of Capital (WACC) of 6.34%. This is calculated using a Cost of Equity of 7.32% (via CAPM with a beta of 0.57) and a pre-tax Cost of Debt of 4.51%, with an equity weight of 73.87% in the capital structure.

Question 2

Is Pacira BioSciences, Inc. Common Stock's WACC high or low?

Accepted Answer

Pacira BioSciences, Inc. Common Stock's WACC of 6.34% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Pacira BioSciences, Inc. Common Stock's WACC calculated?

Accepted Answer

Pacira BioSciences, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.32% is derived from the CAPM model using a beta of 0.57. The pre-tax Cost of Debt (Rd) is 4.51%. The capital structure is 73.87% equity and 26.13% debt.

Pacira BioSciences, Inc. Common Stock (PCRX) — WACC 分析

WACC 构成

解读

Pacira BioSciences, Inc. Common Stock（PCRX）WACC：6.34%

WACC计算器

Pacira BioSciences, Inc. Common Stock（PCRX） WACC 解读

PCRX 公司分析

PCRX DCF 估值

继续做同行对比